Cargando…
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study
BACKGROUND: Non-clinical evidence and a few human studies with short follow-ups suggest increased risk of dyslipidaemia in the post-acute phase of COVID-19 (ie, >30 days after SARS-CoV-2 infection). However, detailed large-scale controlled studies with longer follow-ups and in-depth assessment of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Lancet, Diabetes & Endocrinology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873268/ https://www.ncbi.nlm.nih.gov/pubmed/36623520 http://dx.doi.org/10.1016/S2213-8587(22)00355-2 |